Ally Bridge Group (Ny) LLC Tyra Biosciences, Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $107 Million
- Q2 2024
A detailed history of Ally Bridge Group (Ny) LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 264,660 shares of TYRA stock, worth $6.18 Million. This represents 3.97% of its overall portfolio holdings.
Number of Shares
264,660Holding current value
$6.18 Million% of portfolio
3.97%Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
77Shares Held
43.4MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA10.4MShares$243 Million2.51% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$151 Million5.73% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$109 Million2.28% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$103 Million85.38% of portfolio
-
Nextech Invest Ag4.06MShares$94.7 Million12.24% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $980M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...